www.pharmalive.com

www.pharmalive.com
Share

www.pharmalive.com

 •  August 2

U.S. FDA Approves Expanded Labeling for Epclusa for the Treatment of Chronic Hepatitis C in Patients Co-Infected with HIV – New Data for First Approved Pan-genotypic Once-Daily Single Tablet Regimen for Chronic Hepatitis C Virus Infection – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (NASDAQ: GILD) today announced that the U.S. Food...

www.pharmalive.com

 •  May 25

By Alex Keown, BioSpace.com Breaking News Staff BASEL, Switzerland – Roche (RHHBY) is investigating reports of a German patient who was diagnosed with a deadly brain infection called progressive multifocal leukoencephalopathy after taking one dose of the company’s newly-approved multiple sclerosis drug Ocrevus. According to reports, the patient...

www.pharmalive.com

 •  April 25

By John Kamp • Executive Director of the Coalition for Healthcare Communication While the future of the biopharma and device industries is mostly dependent on what happens in labs and clinical trials, their ability to innovate and successfully market medicines, devices and services operates in a policy soup often flavored by who occupies senior...